CPC
NRIX icon

Cookson Peirce & Co’s Nurix Therapeutics NRIX Stock Holding History

Cookson Peirce & Co’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558K Buy
+23,000
New +$392K 0.02% 244

Other funds holding NRIX

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WFA
WestHill Financial Advisors San Rafael, California $587M AUM 20.13% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ISWM
Intesa Sanpaolo Wealth Management Ville De Luxembourg $500M AUM

Cookson Peirce & Co's NRIX Position: Q2 2026 in Review

Cookson Peirce & Co opened a new position in Nurix Therapeutics (NRIX) in Q2 2026: 23,000 shares worth $558K. The stake represents 0.02% of the portfolio and ranks #244 among its holdings.

24 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Cookson Peirce & Co held 23,000 shares of Nurix Therapeutics worth $558K as of Q2 2026.
  • Nurix Therapeutics was a new Cookson Peirce & Co position in Q2 2026.
  • Nurix Therapeutics made up 0.02% of Cookson Peirce & Co's portfolio in Q2 2026, its #244 holding.
  • 24 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.